A positive genetic testing with the finding of a heterozygous pathogenic NF1 variant has been recently incorporated in the revised International Consensus Criteria for the diagnosis of Neurofibromatosis type I.19 This evidence concerns the gene NF1 and neurofibromatosis type 1.